Editorial Commentary
Sequential treatment of metastatic renal cancer in a complex evolving landscape
Abstract
The large armamentarium of therapies available today for metastatic clear cell renal cell carcinoma (mCCRCC) has prolonged the survival of these patients in real-life as many of them are treated outside clinical trials with a sequential treatment strategy.
